This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Alexander R. Todd, Baron Todd | |
|---|---|
| Name | Alexander R. Todd, Baron Todd |
| Birth date | 2 October 1907 |
| Birth place | Glasgow, Scotland |
| Death date | 10 January 1997 |
| Death place | Cambridge, England |
| Occupation | Chemist |
| Known for | Nucleotides, nucleosides, nucleic acids, organic chemistry |
| Awards | Nobel Prize in Chemistry (not recipient) |
Alexander R. Todd, Baron Todd was a Scottish organic chemist noted for elucidating the structure and synthesis of nucleotides, nucleosides and nucleotide coenzymes, contributing to the chemical understanding central to DNA and RNA research. He played a pivotal role in postwar British science policy, linking academic institutions such as University of Edinburgh and University of Cambridge with national research bodies including the Royal Society and the Medical Research Council (United Kingdom). Todd's work influenced contemporaries and successors across biochemistry, molecular biology, and pharmacology.
Todd was born in Glasgow and educated at Hillhead High School and Glasgow University, where he studied under James Walker and took part in research influenced by earlier figures such as Joseph Lister and Lord Kelvin. He won a scholarship to Trinity College, Cambridge, interacting with scholars at King's College, Cambridge and laboratories linked to Imperial College London, while contemporaries included John Cockcroft and Alexander Fleming. Todd completed a PhD supervised within networks connected to Robert Robinson and the Chemical Society.
Todd's research established chemical routes to synthesize nucleotides and nucleosides, building on the foundations laid by Phoebus Levene, Erwin Chargaff, and Oswald Avery. He characterized the glycosidic bonds in adenosine, guanosine, cytidine, and uridine, and clarified phosphate ester linkages akin to structures central to Watson and Crick models. His laboratory developed methodologies used by researchers at Cambridge University and University of Oxford laboratories of Francis Crick, James Watson, and Maurice Wilkins. Todd's protocols influenced biochemical studies in institutions such as Max Planck Society, Rockefeller University, and Institut Pasteur and were applied in investigations by scientists like Severo Ochoa and Marshall Nirenberg on nucleic acid function.
He published on synthesis pathways that intersected with work by Emil Fischer, Paul Karrer, and Arthur Harden, enabling advances in enzymology studied at Karolinska Institute and Cold Spring Harbor Laboratory. Todd's mechanistic approaches were cited in research across Cambridge School of Biochemistry, University of Manchester, King's College London, and University College London.
Todd held positions at the University of Edinburgh and later at the University of Cambridge as Professor of Chemistry and head of a department that collaborated with the Medical Research Council (United Kingdom), the Royal Institution, and the Wellcome Trust. He mentored doctoral students who moved to posts at Imperial College London, ETH Zurich, and University of California, Berkeley. Todd served on advisory panels for the Ministry of Defence (United Kingdom), the Department of Education and Science (United Kingdom), and international bodies such as the European Molecular Biology Organization and the United Nations Educational, Scientific and Cultural Organization.
Todd was elected to leadership roles including President of the Royal Society and Deanship duties resonant with administrators at Trinity College, Cambridge and fellows of All Souls College, Oxford. He liaised with industrial research at corporations like GlaxoSmithKline, Pfizer, and I.C.I. on pharmaceutical applications of nucleotide chemistry.
Todd received numerous distinctions comparable to honorees such as Max Perutz, Dorothy Hodgkin, and Ernest Rutherford. He was appointed to the Order of Merit (United Kingdom), created a life peer as Baron Todd, and was awarded medals by societies including the Royal Society of Chemistry, the Chemical Society (Great Britain), and the Royal Medal. He was elected a Foreign Member of the National Academy of Sciences (United States), an honorary member of the Académie des sciences and received honorary degrees from University of Oxford, University of Cambridge, Harvard University, Yale University, University of Tokyo, University of Toronto, McGill University, and University of Melbourne.
Todd married and maintained friendships with scientists across Europe and North America, including exchanges with Niels Bohr's circle, collaborations with Linus Pauling-affiliated chemists, and correspondence with figures such as Max Delbrück and Sydney Brenner. He enjoyed connections to cultural institutions like the British Museum and Royal Opera House and engaged with policymakers at 10 Downing Street and the Parliament of the United Kingdom during his advisory tenure.
Todd's legacy is reflected in collections and endowments at University of Cambridge, archival materials held by the Royal Society, and named fellowships administered by the Wellcome Trust and the Royal Society of Chemistry. His chemical syntheses underpin technologies developed at GlaxoSmithKline, Biogen, Genentech, and academic spinouts from Cambridge Science Park. Todd's influence extends to curricula at University of Edinburgh, Imperial College London, and University of Oxford, and his work is commemorated alongside peers like Frederick Sanger, John Kendrew, and Sydney Brenner in histories of molecular biology and biochemistry.
Category:Scottish chemists Category:Fellows of the Royal Society Category:Barons created by Elizabeth II